Sarembock Ian J
Cardiovascular Division and Cardiovascular Research Center, University of Virginia Health System, Box 800158, Charlottesville, VA 22908-0158, USA.
Curr Diab Rep. 2004 Feb;4(1):13-9. doi: 10.1007/s11892-004-0005-9.
Stents have become the technique of choice for percutaneous revascularization, but in-stent restenosis has remained a clinical challenge. This brief article summarizes the incidence, patterns, and proposed mechanisms of restenosis and outlines its contemporary management with specific focus on the diabetic patient. It includes a synopsis of the strategy of drug-eluting stents, which is the most recent and major advance in percutaneous coronary intervention.
支架已成为经皮血管重建的首选技术，但支架内再狭窄仍然是一项临床挑战。这篇短文总结了再狭窄的发生率、模式及推测机制，并概述了其现代治疗方法，特别关注糖尿病患者。文中还简要介绍了药物洗脱支架策略，这是经皮冠状动脉介入治疗领域最新且最重大的进展。
